Skip Navigation
Skip to contents



10 results

Fatal Ifosfamide-Induced Metabolic Encephalopathy in Patients with Recurrent Epithelial Ovarian Cancer: Report of Two Cases

Shin YJ, Kim JY, Moon JW, You RM, Park JY, Nam JH

  • Cancer Res Treat.
  • 2011 Dec;43(4):260-263.
Central nervous system (CNS) toxicity has been reported in approximately 10-30% of patients receiving intravenous infusions of ifosfamide. Encephalopathy is a rare but serious CNS adverse reaction in these patients,...
Cyclosporine in Relapsed Subcutaneous Panniculitis-like T-Cell Lymphoma after Autologous Hematopoietic Stem Cell Transplantation

Jung HR, Yun SY, Choi JH, Bae SH, Ryoo HM, Kum YS

  • Cancer Res Treat.
  • 2011 Dec;43(4):255-259.
Subcutaneous panniculitis-like T-cell lymphoma (SPTCL) is a rare T-cell lymphoma characterized by involvement of the subcutaneous tissue of neoplastic T lymphocytes. SPTCL with hemophagocytic syndrome (HPS) is associated with an...
Expression of BamHI-A Rightward Transcripts in Epstein-Barr Virus-Associated Gastric Cancers

Jang BG, Jung EJ, Kim WH

  • Cancer Res Treat.
  • 2011 Dec;43(4):250-254.
PURPOSE: About 10% of all gastric cancers (GCs) are Epstein-Barr virus (EBV)-associated. However, the oncogene of EBV in gastric carcinogenesis has not yet been established. In the present study, we...
Clinical Outcome of Gastric Cancer Patients with Bone Marrow Metastases

Kwon JY, Yun J, Kim HJ, Kim KH, Kim SH, Lee SC, Kim HJ, Bae SB, Kim CK, Lee NS, Lee KT, Park SK, Won JH, Hong DS, Park HS

  • Cancer Res Treat.
  • 2011 Dec;43(4):244-249.
PURPOSE: The prognosis of gastric cancer patients with bone marrow metastases is extremely poor. The current study was conducted to evaluate the clinical outcomes of advanced gastric cancer patients with...
Prognostic Factors of Second and Third Line Chemotherapy Using 5-FU with Platinum, Irinotecan, and Taxane for Advanced Gastric Cancer

Park JS, Lim JY, Park SK, Kim MK, Ko HS, Yoon SO, Kim JW, Choi SH, Cho JY

  • Cancer Res Treat.
  • 2011 Dec;43(4):236-243.
PURPOSE: The aims of this study are to find out whether the sequence of chemotherapeutic regimens including second- and third-line taxane and irinotecan influences the survival of patients with unresectable...
Adjuvant Effect of IV Clodronate on the Delay of Bone Metastasis in High-Risk Prostate Cancer Patients: A Prospective Study

Rodrigues , Hering FO, Meller A

  • Cancer Res Treat.
  • 2011 Dec;43(4):231-235.
PURPOSE: High-risk prostate cancer patients undergoing treatment often experience biochemical recurrence. The use of bisphosphonates as an adjuvant treatment delays skeletal events, yet whether or not bisphosphonates also delay metastastic...
A Phase II Study of Modified FOLFOX4 for Colorectal Cancer Patients with Peritoneal Carcinomatosis

Lee DH, Oh SY, Lee YR, Huh SJ, Yoon HH, Kim SH, Lee S, Lee JH, Kim Y, Kim HJ, Kwon HC

  • Cancer Res Treat.
  • 2011 Dec;43(4):225-230.
PURPOSE: Peritoneal carcinomatosis (PC) of colorectal cancer (CRC) is common and is the second most common cause of death. Clinical studies regarding chemotherapy for CRC with PC have been classically...
Gemcitabine Plus Platinum Combination Chemotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Analysis

Chun SH, Lee JE, Park MH, Kang JH, Kim YK, Wang YP, Park JK, Kim HK

  • Cancer Res Treat.
  • 2011 Dec;43(4):217-224.
PURPOSE: This study aimed to analyze the efficacy and toxicity of gemcitabine plus platinum chemotherapy for patients aged 70 years or older with advanced non-small-cell lung cancer (NSCLC). MATERIALS AND METHODS:...
Phase II Study of S-1 Plus Either Irinotecan or Docetaxel for Non-small Cell Lung Cancer Patients Treated with More Than Three Lines of Treatment

Kim DY, Lee DH, Jang SJ, Kim SW, Suh C, Lee JS

  • Cancer Res Treat.
  • 2011 Dec;43(4):212-216.
PURPOSE: This study was designed to evaluate the efficacy of a combination treatment of S-1 plus either irinotecan or docetaxel for advanced/metastatic non-small cell lung cancer (NSCLC) patients who have...
Systems Biology Approaches to Decoding the Genome of Liver Cancer

Lee JS, Kim JH, Park YY, Mills GB

  • Cancer Res Treat.
  • 2011 Dec;43(4):205-211.
Molecular classification of cancers has been significantly improved patient outcomes through the implementation of treatment protocols tailored to the abnormalities present in each patient's cancer cells. Breast cancer represents the...

Go to Top

Copyright © 2020 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: